CureMetrix Solutions for the Public Sector

The first FDA-cleared AI-based triage solution for mammography in the U.S. Enables radiologists to triage, sort and prioritize mammography worklists based on suspicious cases that may need immediate attention.

• Up to 30% faster reading time

Watch the demo

An investigational SaaS intended to identify, mark and score regions of interest on screening and diagnostic mammograms.

• 27% increase in breast cancer detection,
  without increasing recall rates
• 69% reduction in false positives,
  over non-AI solutions

Watch the demo

An investigational artificial intelligence-based software that helps doctors assess a woman’s risk of coronary heart disease (CHD) from the same mammogram used to identify breast cancer - investigational.

cmAngio produces a CureMetrix Bradley Score™ based on the existence and characteristics of breast arterial calcifications in the mammogram. The Bradley Score and their associated risk of CHD can be tracked over time to help patients and doctors understand their changing health profile.

An investigational AI-based solution for mammography designed to automate the classification of breast density accurately, consistently, and quickly with a high level of confidence.